Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Covid-19 — Navigating the Uncharted
TAKE-HOME MESSAGE
-
Coronavirus Disease 2019, now officially named COVID-19, is anticipated to be a large global health threat. The outbreak continues to evolve, and poses significant challenges for the public health, research, and medical communities. This editorial reflects on the outbreak and highlights important information to consider while interpreting available data recently published about the outbreak.
- COVID-19 provides a reminder of the need for constant surveillance, prompt diagnosis, and robust research to understand the basic biology of new organisms and our susceptibilities to them, as well the need for continued development of effective global countermeasures.
abstract
This abstract is available on the publisher's site.
Access this abstract nowThe latest threat to global health is the ongoing outbreak of the respiratory disease that was recently given the name Coronavirus Disease 2019 (Covid-19). Covid-19 was recognized in December 2019. It was rapidly shown to be caused by a novel coronavirus that is structurally related to the virus that causes severe acute respiratory syndrome (SARS). As in two preceding instances of emergence of coronavirus disease in the past 18 years — SARS (2002 and 2003) and Middle East respiratory syndrome (MERS) (2012 to the present) — the Covid-19 outbreak has posed critical challenges for the public health, research, and medical communities.
Additional Info
Disclosure statements are available on the authors' profiles:
Covid-19 — Navigating the Uncharted
N. Engl. J. Med 2020 Feb 28;[EPub Ahead of Print], AS Fauci, HC Lane, RR RedfieldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Respiratory Medicine
Dr. Anthony Fauci is a lead scientist and long-time director for the National Institute of Allergy and Infectious Diseases (NIAID). In this editorial, Dr. Fauci summarizes what we currently know about COVID-19 based on preliminary reports from China, stresses the dynamically changing landscape, outlines opportunities for research, and reminds us of challenges ahead as we face emerging pathogens.